Notes / Company

Cohance Lifesciences Ltd.

COHANCE BSE 543064 ISIN INE03QK01018 CDMO

Fundamentals

Market cap: ₹17,523 cr
P/E: 97.77×
ROE: 15.79%
Debt / equity: 0.05
52-week range: 266.70 — 1121.15

Research on Tijori Finance

Company snapshot

Cohance Lifesciences Ltd.

CDMO

₹17,520 cr

P/E 97.75×

Latest quarter · Mar 2026

Sales₹619 cr

Net profit₹8 cr

Op. margin+15.9%

EPS₹0.51

Strength & growth

Debt / equity0.05×

Current ratio2.34×

Sales CAGR+37.0%

The timeline — 1 note on Cohance Lifesciences Ltd.

June 2026

18 Jun 26 · 3:29 PM IST Lead

Lead · Credit · Mid cap

Cohance promoters pledge 54% of equity to refinance $285M debt

Jusmiral Holdings and Berhyanda have gone from zero encumbrance to pledging their entire stake. The loan amounts to 14.5% of market cap.

Verify on exchange BSE filings for COHANCE NSE filings for COHANCE Tijori Finance company page